NEW YORK (GenomeWeb News) – The North Carolina Biotechnology Center sees the state as a potential hub for personalized medicine research and business, and has provided $100,000 for a project to begin exploring the possibility of creating a center that would focus on commercializing technologies to individualize medical diagnosis and treatment of each patient.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.